SI2542227T1 - Takojšnje zadržano razdeljevanje zdravila - Google Patents

Takojšnje zadržano razdeljevanje zdravila Download PDF

Info

Publication number
SI2542227T1
SI2542227T1 SI201131396T SI201131396T SI2542227T1 SI 2542227 T1 SI2542227 T1 SI 2542227T1 SI 201131396 T SI201131396 T SI 201131396T SI 201131396 T SI201131396 T SI 201131396T SI 2542227 T1 SI2542227 T1 SI 2542227T1
Authority
SI
Slovenia
Prior art keywords
disease
active agent
disorders
acid
syndrome
Prior art date
Application number
SI201131396T
Other languages
English (en)
Inventor
Alexander Mullen
Howard Stevens
Sarah Eccleston
Original Assignee
University Of Strathclyde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Strathclyde filed Critical University Of Strathclyde
Publication of SI2542227T1 publication Critical patent/SI2542227T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Claims (10)

  1. TAKOJŠNJE/ZADRŽANO RAZDELJEVANJE ZDRAVILA EP 2 542 227 B1 PATENTNI ZAHTEVKI
    1. Formulacija pod pritiskom prevlečene tablete, za takojšnjo, čemur sledi zadržano sproščanje aktivnega sredstva, tableta obsega (a) jedro, ki vsebuje aktivno sredstvo skupaj s pomožno snovjo(mi); in (b) plast s zadržanim sproščanjem, ki obdaja jedro, in vsebuje vosek in mikronizirano nizko substituirano hidroksiipropil celulozo (L-HPC) s povprečnim premerom 20 pm, ki je netopna v vodi in vsebuje glukozni skelet, substituirano s hidroksiipropilnimi skupinami, in ima molekulsko maso okoli 115,000 in hidroksiipropil celulozno vsebnost okoli 8% v razmerju 40 : 60 do 60 : 40 m/m; kjer sloj z zadržanim sproščanjem v bistvu zakasni sproščanje aktivnega sredstva v jedru za od 3 do 8 ur po dajanju tablete osebku nakar pride do impulznega sproščanja aktivnega sredstva iz jedra, tako da se vsaj 70% aktivnega sredstva v jedru sprosti v 5 - 45 min; in (c) plast zgornje prevleke, ki vsebuje del aktivnega sredstva skupaj s sladkorjem in L-HPC, pri čemer se vsaj 70-90% aktivnega sredstva sprosti v roku 5 - 45 min po dajanju tablete osebku.
  2. 2. Pod pritiskom prevlečena tableta po zahtevku 1, ki nadalje obsega količino aktivnega sredstva v plasti z zadržanim sproščanjem, ki je enaka ali različna od aktivnega sredstva v plasti, ki obdaja jedro in/ali plasti zgornje prevleke, v plasti z zadržanim sproščanjem.
  3. 3. Pod pritiskom prevlečena tableta po kateremkoli predhodnem zahtevku, ki obsega eno ali več naslednjih aktivnih sredstev: Gastro zdravila Antacidi - aluminijev hidroksid, magnezijev karbonat, magnezijev trisilikat, hidrotalcit, simetikon alginati, Antispazmodika - atropinijev sulfat, dicikloverin hidroklorid, hioscin butilbromin, propanthelin bromid, alverin citrat, mebeverinijev klorid, Motilitetni stimulansi - metoklorpramid, domperidon H2 - antagonisti receptorjev - cimetidin, famotidinizatidin, ranitidin antimuskarinika - pirenzepin kelati - trikotijev dicitratibizmutat, sukralfat, Prostaglandinski analogi - misoprostol Aminosalicilati - balsazid natrij, mesalazin, olsalazin, sulfasalazin Kortikosteroidi - beklometazon dipropionat, budenozid, hidrokortizon, pednizolon, Vpliv na imunski odziv - ciklosporin, merkaptopurin, metotreksat, adalimumab, infliksimab Stimulantni odvajalci - bisacodil, dantron, dokusat, natrijev pikosulfat, Zdravila, ki vplivajo na biološko sestavo in pretok - ursodeoksiholna kislina Sekceptorji žolčnih kislin - kolestiramin, oksifentenciklin, kamilofin, mebeverin, trimebutin, rociverin, dicicloverin, diheksiverin, difemerin, piperidolat benzilon, mepenzolat, pipenzolat, glikopironij, oksifenonij, pentienat, metantelin, propantelin, otilonijev bromid, tridiheksetil, izopropamid, heksociklij, poldin, bevonij, difemanil, tiemonijev jodid, prifinium bromid, timepidijev bromid, fenpiverinium papaverin, drotaverin, antagonisti moksaverin 5-HT3 (kot so Alosetron, Cilansetron), agonisti 5-HT4 (kot so Mosaprid, Prucaloprid, Tegaserod) fenpiprane, diizopromin, klorbenzoksamin, pinaverij, fenoverin, idanpramin, proksazol, alverin, trepibuton, izomethepten, karoverin, floroglucinol, silikoni, trimetildifenilpropilamin atropin, hiosciaminamin skopolamin (kot so butilscopolamin, metilscopolamin), metilatropin, fentonij, cimetropijev bromid predvsem antagonisti dopamina (kot so metoklopramid/bromoprid, klebobrid, domperidon, alizaprid), agonsit 5-HT4 (kot sta cinitaprid, cisaprid), Zaviralci protonske črpalke omeprazol, iansoprazol, pantoprazol, esomeprazol, natrijev rabeprazol, opioidi in antagonisti receptorjev opioidov-npr. kodein, morfin, loperamid, difenoksilat, metilnaltrekson bromid Analgetik acetaminofen diklofenak diflunisal etodolak fenoprofen flurbiprofen ibuprofen indometacin ketoprofen ketorolac meklofenamat mefenaminska kislina meloksikam nabumeton naproksen oksaprozin fenilbutazon piroksikam sulindak tolmetin celekoksib buprenorfin butorfanol kodein hidrokodon hidromorfon levorfanol meperidin metadon morfin nalbufin oksikodon oksimorfon pentazocin, propoksifen tramadol kodein Zdravila za spanie Hipnotiki - nitrazepam, flurazepam, loprazolam, lormetazepam, temazepam, zaleplon, zolpidem, zopiklon, kloral hidrat, triklofos, klometiazol, kvazepam, triazolam estazolam klonazepam, alprazolam, eszopiklon, rozerem, trazodon, amitriptilin doksepin, benzodiazepinska zdravila, melatonin, difenhidramin in zeliščna zdravila, kot je valerian. Kardiovaskularna zdravila Srčni glikozidi - digoksin, digitoksin, Inhibitorji fosfodiesteraze - enoksimon, milrinon Tiazidi in sorodni diuretiki - bendroflumetiazid, klortalidon, ciklopentiazid, inapamid, metolazon, ksipamid Diuretiki - furosemid, bumetanid, torasemid, Diuretiki, ki varčujejo s kalijem in antagonisti aldosterona - amilorid hidroklorid, triamteren, eplerenon, spironolakton, Osmotski diuretiki - manitol Zdravila za aritmije - adenozin, amiodaron hidroklorid, disopiramid, flekainid acetat, propafenon hidroklorid, lidokain hidroklorid, Beta adrenoreceptorski blokatorji - propanalol, atenolol, acebutolol, bisoprolol fumarat, karvedilol, celiprolol, esmolol, lebatolol, metoprolol tartrat, nadolol, nebivolol, oksprenolol, pindolol, solatol, timolol, Hipertenzija - ambrisentan, bosentan, diazoksid, hidralazin, iloprost, minoksidil, sildenafil, sitaksentan, natrijev nitroprusid, klonidin, metildopa, moksonidin, gvanetidin monosulfat, doksazosin, indoramin, prazosin, terazosin, fenoksibenzamin, fentolamin mesilat, Zdravila, ki vplivajo na renin-angiotenzin sistem - captropril, cilazapril, enalapril maleat, fosinopril, imidapril, lisinopril, moeksipril, perindopril erbumin, kuinapril, ramipril, trandolapril, candesartan cileksetil, eprosartan, irbesartan, losartan, olmesartan medoksomil, telmisartan, valsartan, aliskiren. Nitrati, blokatorji kalcijevih kanalov in antianginalna zdravila - gliceril trinitrat, izosorbidni dinitrat, izosorbid mononitrat, amlodipin, diltiazem, felodipin, izradipin, lacidipin, lercanidipin, nikardipin, nifedipin, nimodipin, verapamil, ivabradin, nikorandil, ranolazine, Periferni vazodilatatorji in sorodna zdravila - cilostazol, inositol nikotinat, moksizilat, naftidrofuril oksalat, pentoksifilin, Simpatomimetiki - dopamin, dopeksamin, efedrin, metaraminol, noradrenalinski kislinski tartrat, norefidrin bitartrat, fenilefidrin, Antikoagulanti in protamin - heparin, bemiparin, dalteparin, enokaparin, tinzaparin, danaparoid, bivalirudin, lepirudin, epoprostenol, fondaprinuks, varfarin, acenokumarol, fenindion, dabigatran eteksilat, rivaroksaban, protamin sulfat, Antiplatelet zdravila - abciksimab, asiprin, klopidogrel, dipiridamol, eptifibatid, prasugrel, tirofiban, Fibrinolitična in antifibrinolitična zdravila - alteplaza, reteplaza, streptokinaza, tenekteplaza, urokinaza, etamsilat, traneksamična kislina, Zdravila za uravnavanje lipidov - atorvastatin, fluvastatin, pravastatin, rosuvastatin, simvastatin, kolesevam, colestiramin, kolestipol, ezetimib, bezafibrat, ciprofibrat, fenofibrat, gemfibrozil, acipmoks, nikotinska kilsina, omega tri spojine maščobnih kislin, etanolamin oleat, natrijev tetradecil supat. Zdravila CNS - benperidol, klorpromazin, flupentiksol, haloperidol, levomepromazin, periciazin, perfenazin, pimozid, prokloroperazin, promazin, sulpirid, trifluoperazin, zuklopentiksol, amisulprid, aripiprazol, klozapin, olanzapin, paliperidon, kvetiapin, riperidon, sertindol, zotepin, flupentiksol, fluphenazin, olanzapin-embonat, palmitat pipotiazin, risperidon, zuklopentiksol-dekanoat, karbamazepin, valproat, valprojska kislina, litijev karbonat, litijev citrat, amitriptilin, klomipramin, dosulepin, imipramin, lofepramin, nortriptilin, trimipramin, mianserin, trazodon, fenelzin, izokarboksazid, tranilcipromin, moklobemid, citalopram, escitalopram, fluoksetin, fluvoksamin, paroksetin, sertralin, agomelatin, duloksetin, flupentiksol, mirtazapin, reboksetin, tritofan, venflaksin, atomoksetin, deksametamin, metilfenidat, modafinil, eslikarbazepin, okarbazepen, etosuksimid, gabapentin, pregabalin, lakozamid, lamotrigin, levetiracetam, fenobarbital, primidon, fenitoin, rufinamid, tiagabin, topiramat, vigabatrin, zonisamid, ropinirol, rotigotin, beneldopa, levodopa, co-kareldopa, rasagilin, selegilin, entakapon, tolkapon, amantidin, orfenadrin, prociklidin, triheksifenidil, haloperidol, piracetam, riluzol, tetrabenazin, acamprozat, disulfiram, bupropion, varenicilin, buprenorfin, lofeksidin, donepezil, galantamin, memantin, rivastigimin. Anti-infektivi - benzilpenicilin, fenoksimetilpenicilin, flukloksacilin, temocilin, amoksicilin, ampicilin, co-amoksiklav, co-fluampicil, piperacilin, tikarcilin, pivmecilinam, cefalosporini, cefaklor, cefadroksil, cefaleksin, cefiksem, cefotaksim, cefradin, ceftazidim, cefuroksim, ertapenem, imipenem, meropenem, aztreonam, tetraciklin, demeklociklin, doksociklin, limeciklin, minociklin, okstetraciklin, tigeciklin, gentamicin, amikacin, neomicin, tramramicin, eritromicin, azitromicin, klaritromicin, telitromicin, klindamicin, kloramfenikol, fuzidična kislina, vankomicin, teikoplanin, daptomicin, linezolid, kuinupristin, kolistin, ko-trimoksazol, sulpadiazin, trimetoprim kapreomicin, cikloverin, etambutol, izoniazid, pirazinamid, rifabutin, rifampicin, streptomicin, dapson, klofazimin, metronidazol, tinidazol, ciproflaksacin, levoflaksacin, moksifloksacin, nalidiksova kislina, norflakin, orflaksacin, nitrofurantoin, metenaminijev hipurat, amfotericin, anidulafungin, kaspofungin, flukonazol, flucitozin, griseofluvin, itraconzol, ketokonazol, mikafungin, nistatin, posakonazol, terbinafin, vorikonazol, abacavir, didanozin, emtricitabin, lamivudin, stavudin, tenofovir disoproksil, zidovudin, atazanavir, darunavir, fosamprenavir, indinavir, lopinair, nelfinavir, ritonavir, sakvinavir, tipranavir, efavirenz, etravirin, nevarapin, enfuvirtid, maraviroc, raltegravir, aciklovir, famciklovir, inosin pranobeks, valaciklovir, cidofovir, gangciklovir, foskarnet, valgangciklovir, adefovir dipivoksil, entekavir, telbivudin, amantadin, oseltamivir, zanamivir, palivizumab, ribavirin, artemeter, klorokuin, meflokuin primaquin, proguanil, pirimetamin, kinin, doksiciklin, diloksanid furoat, metronidazol, tinidazol, natrijev mepakrin stiboglukonat, atovakuon, pentamidin izetionat, mebendazol, piperazin, Drugo: benztropiprociklidin biperiden, amantadin bromokriptin pergolid entakapon tolkapon selegelin pramipeksol, budesonid, formoterol, kvetiapin fumarat, olanzapin, pioglitazon, montelukast, zoledromska kislina, valsartan, latanoprost, irbesartan, klopidogrel, atomoksetin, deksamfetamin, metilfenidat, modafinil, bleomicin, daktinomicin, daunorubicin, idarubicin, mitomicin, mitoksantron, azacitidin, kapecitabin, kladribin, klofarabin, citarabin, fludarabin, fluorouracil, gemcitabin, merkaptopurin, metotreksat, nelarabin, pemetreksed, raltitreksed, tioguanin, apomorfin, betametazon, kortizon, deflazakort, deksametazon, hidrokortizon, metilprednizolon, prednizolon, triamcinolon, ciklosporin, sirolimus, takrolimus, interferon alfa, interferon beta.
  4. 4. Pod pritiskom prevlečena tableta po zahtevku 3 za uporabo pri postopku zdravljenja ene ali več naslednjih bolezni ali stanj: Bolezni centralnega živčnega sistema, npr. nevrogena bolečina, možganska kap, demenca, Alzheimerjeva bolezen, Parkinsonova bolezen, bolezni nevronske degeneracije, meningitisa, poškodbe hrbtenjače, cerebralnega vazospazma, amiotrofične lateralne skleroze. Kardiovaskularne bolezni, hipertenzija, ateroskleroza, angina, arterijska obstrukcija, periferna arterijska bolezen, miokardna patologija, aritmija, akutni miokardni infarkt, angina, kardiomiopatija, kongestivna srčna okvara, bolezni koronarne arterije, bolezni karotidne arterije, endokarditis, hiperholesterolemij, hiperlipidemija, periferna arterijska bolezen Genitourinarne motnje; erektilna disfunkcija, bolezen sečil, benigna hipertrofija prostate, ledvična cevasta acidoza, diabetična nefropatija, glomerulonefritis, glomeruloskleroza, okužba sečil, fekalna inkontinenca Očesne bolezni glavkom, blefartitis, očesna hipertenzija, retinopatija, konjunktivitis, skleritis, retinitis, keratitis, razjeda roženice, iritisa, korioretinalno vnetje, makularni edem, kseroftalmija Pljučne bolezni, astma, pljučna hipertenzija, akutni respiratorni distresni sindrom, KOPB, emfizem, pljučnica, tuberkuloza, bronhitis, akutni bronhitis, bronhiektazija, bronhiolitis, bronhopulmonalna displazija, bisinoza, kokcidioidomikoza, cistična fibroza, gripa, rak pljuč, mezoteliom Bolezni presnove; hiperkalciurija, hiperglikemija, hipersinemična hipoglikemija, hiperinsulinizem, hiperlizinurija, hipoglikemija Eksokrina in Endokrina; Addisonova bolezen, hipoaldosteronizem Cushingov sindrom, diabetes, golša, hipertiroidizem, hipotiroidizem, tiroiditis, pankreatitis Bolezni jeter, hepatitis, brezalkoholna bolezen maščobnih jeter, ciroza, jetrni rak, primarni sklerozni holangitis, primarna žolčna ciroza, Budd-Chiarijev sindrom, Avtoimunske in vnetne bolezni, revmatoidni artritis multiple skleroze, psoriaza, diabetes, sarkoidoza, Addisonova bolezen, alopecija areata, amiotrofična lateralna skleroza, ankilozirajoči spondilitis, poliartikularni artritis, atopična alergija, tematski dermatitis, avtoimunski hepatitis, celiakija, bolezen šag, bolezen celije, koganski sindrom, Crohnova bolezen, Cushingov sindrom, diabetes mellitus tip 1, endometrioza, eozinofilni fascilitis, fibromialgija/fibromiozitis, gastritis, glomerulonefritis, Gravesova bolezen, Guillain-Barrejev sindrom, Hashimoto-ov encefalitis, Hashimoto-ov tiroiditis, hemolitična anemija, idiopatsko vnetno demielizirajoča bolezen, idiopatska pljučna fibroza, intersticijski cistitis, juvenilni idiopatski artritis, juvenilni revmatoidni artritis, Kavvasaki bolezen, Lichen sclerosus, eritematozni lupus, Menierejeva bolezen, Myasthenia gravis, miozitis, narcolepsija, anemija pervozgodovine, periferni encefalomielitis, polimialgia revmatica, primarna žolčna ciroza, psoriatični artritis, Reiterjev sindrom, revmatoidna vročina, sarkoidoza, šizofrenija, Sjogrenov sindrom, spondiloartropatija, ulcerozni kolitis Mišično-skeletne motnje: osteoartritis, osteoporoza, osteonekroza, artritis, Pagetova bolezen bursitis, costohondritis,tendonitis Kožne nepravilnosti; akne, alopecija, kandidiaza, celuliltis, dermatitis, ekcem, bulosa epidermoliza, eritrasma, herpes, erizipel, folikulitis, impetigo, lišaji, garje, nazofaringitis, trihomikoza ENT motnje; otitis, sinusitis, faringitis, menerejeva bolezen, labirintitis, Drugo: akutna in kronična bolečina, virusna okužba, rak, mastoiditis, maringitis, meditja otitis, rinitis, sinuzitis, sialadenitis, retrofaringealni absces, tonsilofaringitis, Bolezni prebavil; sindrom razdražljivega črevesja, nekrotizirajoči enterolititis, dispepsija brez ulkusov, kronična črevesna pseudo-obstrukcija, funkcionalna dispepsija, pseudo-obstrukturiduodenogastrični refluks kolonije, gastroezofagealna refluksna bolezen, ileus vnetje, gastropareza, zgaga, zaprtje - (npr. zaprtje, povezano z uporabo zdravil kot so opioidi), kolorektalni rak, kolonijevi polipi, divertikulitis, kolorektalni rak, »barrett« požiralnik, krvavitev v prebavnem traktu, celiakija, polipi debelega črevesa, zaprtje, Crohnova bolezen, sindrom cikličnega bruhanja, odloženo gastrično praznjenje (gastropareza), diareja, divertikuloza, razjeda dvanajstnika, inkontinenca, žolčni kamni, plini v prebavnem traktu, gastritis, gastroezofagealna refluksna bolezen, zgaga, Hiatalna kila, hemohromatoza, hemoroidi, Hiatalna kila, Hirschsprungova bolezen, prebavne motnje, ingvinalna kila, laktoza nestrpnost, peptični ulkusi, polipi, porfirija, primarna biljarska ciroza, primarni sklerozni holangitis, proktitis, hitro praznjenje želodca, sindrom kratkega črevesa, razjede na želodcu, ulcerozni kolitis, razjede, VVhipplova bolezen.
  5. 5. Pod pritiskom prevlečena tableta po zahtevkih 1 ali 2, ki obsega aktivno sredstvo, ki je zasnovano za zdravljenje artritisa in/ali akutne bolečine, kjer je aktivno sredstvo po izbiri NSAID, kot je diklofenak.
  6. 6. Pod pritiskom prevlečena tableta po katerem koli od predhodnih zahtevkov, pri čemer je vosek čebelji vosek, karnuba vosek, mikrokristaliničen vosek, hidrogenirano ricinusovo olje ali ester gliceril.
  7. 7. Pod pritiskom prevlečena tableta po zahtevku 6, kjer je gliceril ester glicerol behenat.
  8. 8. Pod pritiskom prevlečena tableta po katerem koli od predhodnih zahtevkov, kjer sta vosek in L-HPC prisotna v razmerju 40 : 60 do 60 : 40 m/m.
  9. 9. Pod pritiskom prevlečena tableta po zahtevku 7, ki vsebuje 50 : 50 m/m razmerja glicerol behenata, pri čemer je uporabljeni LHPC plast z zadržanim sproščanjem.
  10. 10. Pod pritiskom prevlečena tableta po katerem koli od predhodnih zahtevkov za uporabo pri postopku zdravljenja ali profilakse.
SI201131396T 2010-03-05 2011-03-04 Takojšnje zadržano razdeljevanje zdravila SI2542227T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1003731.5A GB201003731D0 (en) 2010-03-05 2010-03-05 Immediate/delayed drug delivery
EP11709765.9A EP2542227B1 (en) 2010-03-05 2011-03-04 Immediate/delayed drug delivery
PCT/GB2011/000314 WO2011107755A2 (en) 2010-03-05 2011-03-04 Immediate/delayed drug delivery

Publications (1)

Publication Number Publication Date
SI2542227T1 true SI2542227T1 (sl) 2018-04-30

Family

ID=42136567

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201131396T SI2542227T1 (sl) 2010-03-05 2011-03-04 Takojšnje zadržano razdeljevanje zdravila

Country Status (13)

Country Link
US (2) US10137091B2 (sl)
EP (1) EP2542227B1 (sl)
JP (2) JP2013521334A (sl)
DK (1) DK2542227T3 (sl)
ES (1) ES2659815T3 (sl)
GB (2) GB201003731D0 (sl)
HU (1) HUE036629T2 (sl)
NO (1) NO2542227T3 (sl)
PL (1) PL2542227T3 (sl)
PT (1) PT2542227T (sl)
SI (1) SI2542227T1 (sl)
TR (1) TR201802201T4 (sl)
WO (1) WO2011107755A2 (sl)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
AU2010275754B2 (en) 2009-07-22 2014-05-15 Grünenthal GmbH Tamper-resistant dosage form for oxidation-sensitive opioids
GB201003766D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Pulsatile drug release
GB201003731D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Immediate/delayed drug delivery
GB201003734D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Delayed prolonged drug delivery
US9415048B2 (en) 2010-07-08 2016-08-16 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for reducing frequency of urination and method of use thereof
US9119878B2 (en) 2010-07-08 2015-09-01 Wellesley Pharmaceuticals, Llc Extended-release formulation for reducing the frequency of urination and method of use thereof
WO2012028319A1 (en) 2010-09-02 2012-03-08 Grünenthal GmbH Tamper resistant dosage form comprising inorganic salt
US10245178B1 (en) 2011-06-07 2019-04-02 Glaukos Corporation Anterior chamber drug-eluting ocular implant
BR112014002022A2 (pt) 2011-07-29 2017-02-21 Gruenenthal Gmbh comprimido resistente à violação proporcionando liberação de fármaco imediata
LT2736497T (lt) 2011-07-29 2017-11-10 Grünenthal GmbH Sugadinimui atspari tabletė, pasižyminti greitu vaisto atpalaidavimu
BR112014006124A2 (pt) * 2011-09-14 2017-04-11 Pozen Inc dosagem faseada de clopidogrel
US10278925B2 (en) 2012-01-04 2019-05-07 Wellesley Pharmaceuticals, Llc Delayed-release formulations, methods of making and use thereof
WO2013103357A1 (en) * 2012-01-04 2013-07-11 Wellesley Pharmaceutical Extended-release formulation for reducing the frequency of urination and method of use thereof
RU2603471C2 (ru) * 2012-01-04 2016-11-27 УЭЛЛСЛИ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Состав с замедленным высвобождением для снижения частоты мочеиспускания и способ его применения
WO2013103356A1 (en) * 2012-01-04 2013-07-11 Wellesley Pharmaceutical Delayed release formulation for reducing the frequency of urination and method of use thereof
US10105330B2 (en) 2012-01-04 2018-10-23 Wellesley Pharmaceuticals, Llc Extended, delayed and immediate release formulation method of manufacturing and use thereof
EP2612663A1 (en) * 2012-01-04 2013-07-10 Wellesley Pharmaceuticals, LLC Extended-release formulation for reducing the frequency of urination and method of use thereof
BR112014016550A8 (pt) * 2012-01-04 2017-07-04 Wellesley Pharmaceuticals Llc formulação de liberação retardada para reduzir a frequência de urinação e método de uso da mesma
EP2612660B1 (en) * 2012-01-04 2020-03-04 Wellesley Pharmaceuticals, LLC Extended-release formulation for reducing the frequency of urination and method of use thereof
EP2612662B1 (en) * 2012-01-04 2020-03-04 Wellesley Pharmaceuticals, LLC Delayed-release formulation for reducing the frequency of urination and method of use thereof
WO2013142197A1 (en) * 2012-03-19 2013-09-26 Wellesley Pharmaceuticals, Llc Extended-release formulation for reducing the frequency of urination and method of use thereof
AU2013248351B2 (en) 2012-04-18 2018-04-26 Grunenthal Gmbh Tamper resistant and dose-dumping resistant pharmaceutical dosage form
JP2015503555A (ja) * 2012-05-11 2015-02-02 ハナル・バイオファーマ・カンパニー・リミテッド ボセンタン制御放出性経口製剤
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US10596127B2 (en) 2013-03-14 2020-03-24 Wellesley Pharmaceuticals, Llc Composition for reducing the frequency of urination, method of making and use thereof
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
JP6466417B2 (ja) * 2013-05-29 2019-02-06 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
EA032465B1 (ru) 2013-07-12 2019-05-31 Грюненталь Гмбх Защищенная от применения не по назначению пероральная фармацевтическая лекарственная форма, содержащая этиленвинилацетатный полимер, и способ ее изготовления
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
AU2014356581C1 (en) 2013-11-26 2020-05-28 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
MY177906A (en) * 2014-02-06 2020-09-25 Sequential Medicine Ltd Composition and method for aiding sleep
JP6655610B2 (ja) 2014-05-29 2020-02-26 グローコス コーポレーション 制御された薬物送達機能を備えるインプラント及びそれを使用する方法
US9707184B2 (en) 2014-07-17 2017-07-18 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
TW201618783A (zh) 2014-08-07 2016-06-01 艾森塔製藥公司 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法
CA2964628A1 (en) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
GB201420306D0 (en) * 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Compositions
GB201420300D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Tablet
GB201420311D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Pharmaceutical processing
US10299745B2 (en) * 2014-12-29 2019-05-28 Loyola University Of Chicago Traceable devices for gastrointestinal use and methods of use and manufacturing the same
US10363288B2 (en) 2015-01-14 2019-07-30 National Jewish Health Insulin mimotopes and methods of using the same
DK3261645T3 (da) 2015-02-27 2021-06-07 Dechra Ltd Stimulering af appetit, håndtering af vægttab og behandling af anoreksi hos hunde og katte
CN107530289A (zh) 2015-02-27 2018-01-02 扣带回治疗学有限公司 三脉冲释放兴奋剂制剂
EP3302458B1 (en) * 2015-05-28 2022-09-07 The Regents of The University of Colorado, A Body Corporate Methods of preventing and treating autoimmunity
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
JP2018526414A (ja) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
WO2017053885A1 (en) 2015-09-25 2017-03-30 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
AU2017236977B2 (en) 2016-03-24 2022-05-26 Immunomolecular Therapeutics, Inc. Methods of treating autoimmune disease
KR102381586B1 (ko) 2016-04-19 2022-04-04 훼링 비.브이. 메살라진의 경구용 약제학적 조성물
JP7021108B2 (ja) 2016-04-19 2022-02-16 コナリス リサーチ インスティテュート アクチェンゲゼルシャフト ニコチンアミドの経口薬学的組成物
AU2017252294B2 (en) 2016-04-20 2021-12-02 Dose Medical Corporation Bioresorbable ocular drug delivery device
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2018009789A1 (en) * 2016-07-08 2018-01-11 Vanderbilt University Treatment and prevention of clostridium difficile colitis using misoprostol
CN107412180B (zh) * 2017-06-17 2020-05-26 江西医学高等专科学校 一种帕利哌酮包芯片及其制备方法
JP7268026B2 (ja) 2017-12-05 2023-05-02 サノビオン ファーマシューティカルズ インク 非ラセミ混合物およびその使用
WO2019113084A1 (en) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Crystal forms and production methods thereof
KR102034694B1 (ko) 2017-12-14 2019-10-22 한국유나이티드제약 주식회사 모사프리드와 라베프라졸을 함유하는 유핵정 복합제제
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
KR102083241B1 (ko) * 2018-02-14 2020-03-02 환인제약 주식회사 라코사미드를 함유하는 약제학적 서방성 조성물
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa
US20190381056A1 (en) 2018-06-17 2019-12-19 Axsome Therapeutics, Inc. Compositions for delivery of reboxetine
US11020402B2 (en) 2018-10-15 2021-06-01 Axsome Therapeutics, Inc. Use of reboxetine to treat narcolepsy
US20200147093A1 (en) 2018-10-15 2020-05-14 Axsome Therapeutics, Inc. Use of esreboxetine to treat nervous system disorders such as fibromyalgia
WO2020212956A1 (en) * 2019-04-18 2020-10-22 Shivalik Rasayan Limited Oral composition of otilonium bromide
BR112021024380A2 (pt) 2019-06-04 2022-04-19 Sunovion Pharmaceuticals Inc Formulações de liberação modificadas e usos das mesmas
HUP1900358A1 (hu) 2019-10-12 2021-04-28 Meditop Gyogyszeripari Kft Lamotrigin és szertralin hatóanyag tartalmú gyógyszerkészítmények, ezek elõállítása és alkalmazása
CN110638791A (zh) * 2019-10-31 2020-01-03 浙江普利药业有限公司 托吡酯缓释胶囊及其制备方法
KR102334701B1 (ko) * 2019-11-29 2021-12-06 한국유나이티드제약 주식회사 프로톤펌프억제제와 모사프리드를 함유하는 유핵정 제제
KR102334699B1 (ko) * 2019-12-10 2021-12-06 한국유나이티드제약 주식회사 프로톤펌프억제제 및 모사프리드를 포함하는 유핵정 제제
UY39094A (es) * 2020-02-27 2021-07-30 Hk Inno N Corp Composición farmacéutica que comprende compuesto derivado de bencimidazol
FR3116439B1 (fr) * 2020-11-26 2023-08-04 Laboratoire Dielen Comprimé pelliculé contenant au moins un principe actif, adapté à l’administration par voie orale dudit au moins un principe actif chez des sujets humains
US11766419B2 (en) * 2021-01-08 2023-09-26 Banasthali Vidyapith Mebeverine as soluble epoxide hydrolase inhibitor
WO2023068839A1 (ko) * 2021-10-21 2023-04-27 한화제약주식회사 몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 안정성이 개선된 필름코팅 정제
WO2023244591A1 (en) * 2022-06-13 2023-12-21 Cinphloro Pharma Llc Phloroglucinol formulations and methods of use

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
LU86099A1 (fr) 1985-09-30 1987-04-02 Pharlyse Formes galeniques a liberation prolongee du verapamil,leur fabrication et medicaments les contenant
US5145644A (en) 1990-12-20 1992-09-08 Allergan, Inc. Hydrogen peroxide destroying compositions and methods of making and using same
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
EP0546593B1 (en) 1991-10-30 1997-09-03 Glaxo Group Limited Multi-layered compositions containing histamine or serotonin antagonists
JPH07223970A (ja) 1994-02-10 1995-08-22 Tanabe Seiyaku Co Ltd 消化管内適所放出製剤
US5558879A (en) * 1995-04-28 1996-09-24 Andrx Pharmaceuticals, Inc. Controlled release formulation for water soluble drugs in which a passageway is formed in situ
US5788987A (en) 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US6312724B1 (en) 1997-04-04 2001-11-06 Isa Odidi Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof
WO1999012424A1 (de) 1997-09-08 1999-03-18 Basf Aktiengesellschaft Verwendung von wasserlöslichen polymerisaten als biozide
JP2001515854A (ja) 1997-09-11 2001-09-25 ニュコメデ ダンマルク アクティーゼルスカブ 非ステロイド性抗炎症薬物質（ＮＳＡＩＤｓ）の改良された開放性多重−単位組成物
SE9704870D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
ES2559766T3 (es) 1998-05-18 2016-02-15 Takeda Pharmaceutical Company Limited Comprimidos disgregables en la boca
AR019935A1 (es) 1998-07-28 2002-03-27 Takeda Pharmaceutical Preparacion solida de desintegracion rapida, uso de una hidroxipropil celulosa poco sustituida en dicha preparacion y metodo para mejorar la capacidad dedesintegracion rapida de la misma
WO2008079102A1 (en) 2005-05-10 2008-07-03 Elan Corporation, Plc Modified release loxoprofen compositions
US6632451B2 (en) * 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
CA2374760A1 (en) 1999-06-18 2000-12-28 Takeda Chemical Industries, Ltd. Quickly disintegrating solid preparations
EP1064937A1 (en) 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
DE60110666T2 (de) 2000-03-17 2006-02-02 Shin-Etsu Chemical Co., Ltd. Feste Zubereitung enthaltend niedersubstituierte Hydroxypropylcellulose und Herstellungsverfahren
JP3698652B2 (ja) 2000-03-17 2005-09-21 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロース含有固形製剤及びその製造方法
JP2001322927A (ja) 2000-05-12 2001-11-20 Shin Etsu Chem Co Ltd 低置換度ヒドロキシプロピルセルロース含有固形製剤及びその製造方法
BR0212950A (pt) 2001-09-28 2004-10-26 Mcneil Ppc Inc Formas de dosagens compósitas tendo uma porção inserida
BR0213634A (pt) 2001-10-08 2004-11-30 Sun Pharmaceutical Ind Ltd Sistema de liberação de droga com ação retardada para um agente antiespasmódico
CN1674877A (zh) 2002-06-07 2005-09-28 兰贝克赛实验室有限公司 控释的多单位药物释放系统
US20040241100A1 (en) 2003-03-17 2004-12-02 Fabre Kramer Pharmaceutical, Inc. Nasally administrable compositions of zolpidem and methods of use
JP4837895B2 (ja) 2003-03-17 2011-12-14 武田薬品工業株式会社 放出制御組成物
US20060177506A1 (en) 2003-03-17 2006-08-10 Shigeo Yanai Release control compositions
KR101192722B1 (ko) * 2003-04-24 2012-10-18 자고텍 아게 정해진 핵 위치를 가지는 서방성 정제
ES2390879T3 (es) * 2003-12-31 2012-11-19 Actavis Group Ptc Ehf. Formulaciones de atomoxetina
US20050220877A1 (en) 2004-03-31 2005-10-06 Patel Ashish A Bilayer tablet comprising an antihistamine and a decongestant
GB0423964D0 (en) 2004-10-28 2004-12-01 Jagotec Ag Dosage form
JP5159303B2 (ja) 2005-03-03 2013-03-06 武田薬品工業株式会社 放出制御組成物
JP2009514989A (ja) 2005-05-10 2009-04-09 エラン コーポレーション ピーエルシー 改変放出ロキソプロフェン組成物
US20070098788A1 (en) 2005-10-28 2007-05-03 Gore Subhash P Non-benzodiazepine hypnotic compositions
AR056633A1 (es) 2005-12-07 2007-10-17 Gador Sa Composiciones farmaceuticas de agentes hipnoticos de accion corta en forma de liberacion modificada y los procedimientos para preparar dichas formulaciones
EP2098250B1 (en) 2006-12-28 2016-09-28 Takeda Pharmaceutical Company Limited Orally disintegrating solid preparation
WO2008129517A2 (en) * 2007-04-23 2008-10-30 Ranbaxy Laboratories Limited A stabilized delayed release pharmaceutical composition of rabeprazole
WO2009154810A2 (en) * 2008-02-25 2009-12-23 Dr. Reddy's Laboratories Ltd. Delivery systems for multiple active agents
TW201006473A (en) 2008-08-13 2010-02-16 Orient Pharma Co Ltd Bi-layer medicine tablet containing Zaleplon
GB201003766D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Pulsatile drug release
GB201003734D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Delayed prolonged drug delivery
GB201003731D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Immediate/delayed drug delivery

Also Published As

Publication number Publication date
EP2542227A2 (en) 2013-01-09
GB201003731D0 (en) 2010-04-21
JP6162197B2 (ja) 2017-07-12
TR201802201T4 (tr) 2018-03-21
GB2491328A (en) 2012-11-28
EP2542227B1 (en) 2017-11-22
US10137091B2 (en) 2018-11-27
HUE036629T2 (hu) 2018-07-30
US11065205B2 (en) 2021-07-20
WO2011107755A3 (en) 2012-05-03
GB201217611D0 (en) 2012-11-14
NO2542227T3 (sl) 2018-04-21
US20130017262A1 (en) 2013-01-17
ES2659815T3 (es) 2018-03-19
US20190125679A1 (en) 2019-05-02
WO2011107755A2 (en) 2011-09-09
DK2542227T3 (en) 2018-02-26
PT2542227T (pt) 2018-02-21
PL2542227T3 (pl) 2018-04-30
JP2013521334A (ja) 2013-06-10
JP2016026227A (ja) 2016-02-12

Similar Documents

Publication Publication Date Title
SI2542227T1 (sl) Takojšnje zadržano razdeljevanje zdravila
SI2542228T1 (sl) Pulzirajoče sproščanje zdravila
JP6162196B2 (ja) 遅延性持続ドラッグデリバリー
TWI617307B (zh) 包含抑制癌細胞之生長的醯胺衍生物及非金屬鹽潤滑劑之藥學組成物
NO20130366A1 (no) Bruk av bindemidler for fremstilling av lagringsstabile formuleringer
JP5517327B2 (ja) 口腔内崩壊錠用組成物
TW200831140A (en) Controlled-release formulation of piperazine-piperidine antagonists and agonists of the 5-HT1A receptor having enhanced intestinal dissolution
Jagdale et al. Development of press-coated, floating-pulsatile drug delivery of lisinopril
AU2013283474B2 (en) Pharmaceutical form for extended release of active substances
EP3150201B1 (en) Composite preparation comprising 5- -reductase inhibitor-containing film coating layer, and method for producing the composite preparation
EP2540318B1 (en) Sustained-release solid preparation for oral use
CA2994073A1 (en) Tablet comprising a core of acetylsalicylic acid with enteric coating and an outer layer with a potassium-competitive acid blocker
JP2022046737A (ja) 安定性及び溶出率が改善されたタダラフィル含有及びタムスロシン含有のカプセル複合製剤
CN104367557A (zh) 无定型药物活性成分与pvp组合物的制备方法
KR20090030452A (ko) ＨＭＧ-ＣｏＡ 환원효소 억제제와 아스피린을 함유하는복합제제
WO2013127539A2 (de) Pharmazeutische formulierungen
Kumar et al. International Journal o Pharmaceutica